References
- KatonWJThe comorbidity of diabetes mellitus and depressionAm J Med200812111 Suppl 2S81518954592
- AliSStoneMAPetersJLThe prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysisDiabet Med2006231165117317054590
- EgedeLENietertPJZhengDDepression and all-cause and coronary heart disease mortality among adults with and without diabetesDiabetes Care2005281339134515920049
- EgedeLEEllisCThe effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetesDiabetes Technol Ther20081021321918473696
- KatonWJRussoJEVon KorffMLong-term effects on medical costs of improving depression outcomes in patients with depression and diabetesDiabetes Care2008311155115918332158
- deGrootMAndersonRFreedlandKEAssociation of depression and diabetes complications: A meta-analysisPsychosom Med20016361963011485116
- LustmannPJClouseRENixBDSertraline for prevention of depression recurrence in diabetes mellitusArch Gen Psychiatry20066352152916651509
- GülserenLGülserenSHekimsoyZComparison of fluoxetine and paroxetine in type 2 diabetes mellitus patientsArch Med Res20053615916515847950
- BognerHRMoralesKHde VriesHFCappolaARIntegrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trialAnn Fam Med201210152222230826
- FilipcicIMargeticBSimunovicIJakovljevicMDepression treatment and its impact upon the quality of life in patients with diabetes type 2 – the Croatian studyPsychiatria Danubina20102223123520562752
- AbrahamianHHofmannPPragerRToplakHDiabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)Neuropsychiatr Dis Treat2009526126619557120
- Osterreichische Diabetes GesellschaftDiabetes mellitus – guidelines for the practice. Revised and expanded 2007 editionWien Klin Wochenschr2009121Suppl 5S187 Article in German
- WhooleyMAAvinsALMirandaJCase-finding instrument for depressionJ Gen Intern Med1997124394459229283
- BeckATBeamesderferAAssessment of depression: the depression inventoryMod Probl Pharmacopsychiatry197471511694412100
- RiedelMMöllerHJObermeierMResponse and remission criteria in major depression – a validation of current practiceJ Psychiatr Res2010441063106820447651
- RushWAWhitebirdRRRushMRDepression in patients with diabetes: does it impact clinical goals?J Am Board Fam Med20082139239718772293
- GonzalezJSSafrenStACaglieroEDepression, self-care and medication adherence in type 2 diabetesDiabetes Care2007302222222717536067
- LustmannPJGriffitiLSFreedlandKEFluoxetine for depression in diabetesDiabetes Care20002361862310834419
- AmsterdamJDShultsJRutherfordNSafety and efficacy of s-citalopram in patients with comorbid major depression and diabetes mellitusNeuropsychobiology20075420821417337914
- LustmannPJWilliamsMWSayurGSFactors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropionDiabetes Care20073045946617327305
- MontgomerySATolerability of serotonin norepinephrine reuptake inhibitor antidepressantsCNS Spectr200813:7Suppl 11273318622372
- Lopez-IborJGuelfiJDPletanYMilnacipran and selective serotonin reuptake inhibitors in major depressionInt Clin Psychophamacol199611Suppl 44146
- ClercGMilnacipran/Fluvoxamine Study GroupAntidepressant eff icacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamineInt Clin Psychopharmacol20011614515111354236
- SechterDVandelPWeillerEA comparative study of milnacipran and paroxetine in outpatients with major depressionJ Affect Disord20048323323615555719
- GonzalezJSPeyrotMMcCarlLADepression and diabetes treatment non-adherence: A meta-analysisDiabetes Care2008312398240319033420
- MarkowitzSGonzalezJSWilkinsonJLSafrenSAA review of treating depression in diabetes: emerging findingsPsychosomatics20115211821300190